University of Patras
Χαρακτηρισμός αυτοαντισωμάτων στη μυασθένεια και μελέτη τους σε πειραματικά μοντέλα της νόσου
Abstract
dc:descriptionMyasthenia gravis (MG) is considered the classical organ specific, autoantibody-mediated, and T cell dependent human autoimmune disease. MG is associated with autoantibodies (autoAbs) against the acetylcholine receptor (AChR) of the neuromuscular junction (NMJ). These autoAbs are found in approximately 85% of the patients with generalized MG (AChR-MG), while the remaining ~15% of MG patients have autoAbs to additional NMJ proteins. MG patients are suffering from fatigability and weakness of skeletal muscles, usually due to destruction of the AChRs in the NMJ. The AChR located in the muscle endplates is a ligand-gated ion channel formed by five homologous subunits with stoichiometry α2βγδ in the embryos and α2βεδ in the adults. The subunits are arranged symmetrically around a central pore and are embedded in the postsynaptic muscle membrane, with their extracellular domains (ECDs) oriented in the synaptic space. Muscle AChRs bear one binding site per α-subunit for acetylcholine (ACh), the neurotransmitter which is responsible for the transmission of the nerve impulse to the muscle fibers. The autoimmune nature of the MG has been proved by several observations supporting the role of anti-AChR autoAbs in the pathogenesis of MG. AChR-MG patients have serum circulating anti-AChR autoAbs, detected also at the NMJ. Moreover, patients’ clinical picture improves after plasma or IgG apheresis. Transplacental transfer of IgG (including anti-AChR autoAbs) from MG mothers to infants is thought to be responsible for the transient MG observed in the newborns. Moreover, the disease can be reproduced in animal models (experimental autoimmune MG, EAMG) either by active immunization with AChR (whole or parts of it), or by passive transfer of MG sera and monoclonal Abs (mAbs) against the AChR. However, although it is clear that animal anti-AChR autoAbs can cause EAMG, it has not yet been directly shown whether the anti-AChR Ab fraction of MG patients’ sera is indeed the only or at least the main pathogenic factor in these sera. The anti-AChR autoAbs in sera of MG patients appear heterogeneous in terms of epitope binding. A large fraction of the autoAbs is directed against a specific region, located at the α-subunits called main immunogenic region (MIR). Its antigenic structure is favored by its position near the synaptic end. In addition to the MIR region, autoAbs against the rest of the α-subunit and the other subunits have also been identified. Epitope variability may explain the lack of correlation between patients’ serum autoAb titers and their clinical condition. Indeed, passive transfer experiments with MG sera have demonstrated the induction of the disease only from certain sera. In addition, passive transfer of the disease with mAbs against the AChR has been observed mostly with the use of anti-MIR Abs. Using recombinant extracellular domains of the human AChR α and β subunits, we have isolated autoAbs from the sera of four MG patients. The ability of these isolated anti-subunit Abs and of the Ab-depleted sera to passively transfer experimental autoimmune MG in Lewis rats was investigated. We found that the isolated anti-subunit Abs were at least as efficient as the corresponding whole sera or whole Ig in causing experimental MG. Abs to both α- and β-subunit were pathogenic although the anti-α-subunit were much more efficient than the anti-β-subunit ones. Interestingly, the autoAb-depleted sera were free of pathogenic activity. The later suggests that the myasthenogenic potency of the studied anti-AChR MG sera is totally due to their anti-AChR autoAbs, and therefore selective elimination of the anti-AChR autoAbs from MG patients may be an efficient therapy for MG. In addition, we showed that the anti-α subunit autoAbs are not the only pathogenic anti-AChR autoAbs though they are much more capable in inducing MG than the anti-β ones.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kordas, Grigorios
- Κόρδας, Γρηγόριος
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44826